Geraci, G.; Sorce, A.; Zanoli, L.; Cuttone, G.; Calabrese, V.; Pallotti, F.; Paternò, V.; Ferrara, P.; Dominguez, L.J.; Polosa, R.;
et al. Relationship Between 8-iso-prostaglandin-F2α and Predicted 10-Year Cardiovascular Risk in Hypertensive Patients. Life 2025, 15, 401.
https://doi.org/10.3390/life15030401
AMA Style
Geraci G, Sorce A, Zanoli L, Cuttone G, Calabrese V, Pallotti F, Paternò V, Ferrara P, Dominguez LJ, Polosa R,
et al. Relationship Between 8-iso-prostaglandin-F2α and Predicted 10-Year Cardiovascular Risk in Hypertensive Patients. Life. 2025; 15(3):401.
https://doi.org/10.3390/life15030401
Chicago/Turabian Style
Geraci, Giulio, Alessandra Sorce, Luca Zanoli, Giuseppe Cuttone, Vincenzo Calabrese, Francesco Pallotti, Valentina Paternò, Pietro Ferrara, Ligia J. Dominguez, Riccardo Polosa,
and et al. 2025. "Relationship Between 8-iso-prostaglandin-F2α and Predicted 10-Year Cardiovascular Risk in Hypertensive Patients" Life 15, no. 3: 401.
https://doi.org/10.3390/life15030401
APA Style
Geraci, G., Sorce, A., Zanoli, L., Cuttone, G., Calabrese, V., Pallotti, F., Paternò, V., Ferrara, P., Dominguez, L. J., Polosa, R., George, J., Mulè, G., & Carollo, C.
(2025). Relationship Between 8-iso-prostaglandin-F2α and Predicted 10-Year Cardiovascular Risk in Hypertensive Patients. Life, 15(3), 401.
https://doi.org/10.3390/life15030401
